SMAD3 and neoplasm: Our findings demonstrated a tumor suppressor role of miR-16-5p in chordoma progression by targeting Smad3, which provides new insight into the molecular mechanism of chordoma and may offer a possible therapeutic strategy for chordoma treatment.